
This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.
Dave Reichert is a technical marketing writer at Precision Nanosystems.

This review examines how microfluidics has been used in the formulation, preclinical, and clinical development of gene-delivery nanoparticles.

Published: September 15th 2017 | Updated: